Filing Details
- Accession Number:
- 0001209191-15-009482
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-04 16:58:27
- Reporting Period:
- 2015-02-02
- Filing Date:
- 2015-02-04
- Accepted Time:
- 2015-02-04 16:58:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235118 | S Randall Livingston | Stanford University Bldg 60, Main Quadrangle Stanford CA 94305 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-02 | 1,000 | $10.73 | 7,149 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-02 | 1,000 | $31.93 | 6,149 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (right to buy) | Disposition | 2015-02-02 | 1,000 | $0.00 | 1,000 | $10.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,250 | 2007-05-25 | 2016-05-25 | No | 4 | M | Direct |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 10, 2014.
- Represents weighted average sale price. Actual sale prices ranged from $31.67 to $32.31.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Billionaire Hedge Funds
